He offered that Bayer’s pharmaceutical division accounts for about 40% of the company’s total employees, and that cost savings will be proportionally tied to the size of each unit. Bayer in ...

Notably, the company warned that 2025 will be weaker ... Sales of glyphosate-based herbicides declined by 19% YoY. Meanwhile, Bayer's Pharmaceutical division has delivered mixed performance.

2025 Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the German company's pharmaceuticals division said in an interview ...

Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions underway for key growth drivers darolutamide, finerenone, and elinzanetant.

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...

(Bloomberg) -- Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the company still faces after its $63 billion acquisition of ...

Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...

The rankings of the top pharmaceutical companies in the world in 2017 presented ... Novo Nordisk and Bayer entered the top 10 this year after crossing the $1 billion market capitalisation value ...

Bayer BAYN-0.85%decrease ... a win for the German pharmaceutical and agricultural conglomerate that still faces litigation in the U.S. The group has been hounded by lawsuits since 2018 when ...

German multinational pharmaceutical and biotechnology company Bayer is seeking to strengthen its presence in India by expanding its portfolio of therapies and enhancing collaborations across the ...